Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-04

Clinical Trial Update: Bioavailability Study With GLPG1972 [Phase 1]

View source ↗

Summary

A Phase 1 bioavailability study of GLPG1972 for osteoarthritis by Galapagos NV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLPG1972

Snippet

Sponsor: Galapagos NV | Conditions: Osteoarthritis | Phase 1 | Status: COMPLETED